Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide
- PMID: 3290683
- DOI: 10.1038/333861a0
Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide
Abstract
Duchenne muscular dystrophy (DMD) is a debilitating X-linked muscle disease. We have used sequence information from complementary DNA clones, derived from the gene that is deleted in DMD patients, to generate an antiserum that stains the surface membrane of intact human and mouse skeletal muscle, but not that of DMD patients and mdx mice. Here we identify the protein reacting with this antiserum as a single component of relative molecular mass 210,000 (Mr = 210K) that fractionates with a low-ionic strength extract of intact human and mouse skeletal muscle. It is therefore distinct from the 400 K protein found in the heavy microsomal fraction of normal muscle and identified as a putative product of the DMD gene. We also analyse further the disease specificity of the antiserum. Positive staining is seen in normal controls, and in samples from patients with a wide range of muscular dystrophies other than DMD. Becker muscular dystrophy, which is allelically related to DMD, was the only other exception, and gave a sporadic staining pattern. The demonstration of a specific defect in the surface membrane of DMD muscle fibres substantiates the hypothesis that membrane lesions may initiate muscle degradation in DMD.
Similar articles
-
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle.Nature. 1988 Jun 2;333(6172):466-9. doi: 10.1038/333466a0. Nature. 1988. PMID: 3287171
-
[Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice].C R Acad Sci III. 1990;311(5):197-204. C R Acad Sci III. 1990. PMID: 2119867 French.
-
Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.Muscle Nerve. 1989 Dec;12(12):1009-16. doi: 10.1002/mus.880121209. Muscle Nerve. 1989. PMID: 2695839
-
Localization of dystrophin in cultures of human muscle.Muscle Nerve. 1989 Jul;12(7):594-7. doi: 10.1002/mus.880120711. Muscle Nerve. 1989. PMID: 2674706 Review.
-
Animal models of muscular dystrophies.Lab Anim Sci. 1998 Feb;48(1):8-17. Lab Anim Sci. 1998. PMID: 9517883 Review.
Cited by
-
Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies.Pharmaceutics. 2021 Feb 19;13(2):278. doi: 10.3390/pharmaceutics13020278. Pharmaceutics. 2021. PMID: 33669654 Free PMC article. Review.
-
Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development.Nucleic Acids Res. 1992 Apr 11;20(7):1725-31. doi: 10.1093/nar/20.7.1725. Nucleic Acids Res. 1992. PMID: 1579466 Free PMC article.
-
Isolation and characterization of different C-terminal fragments of dystrophin expressed in Escherichia coli.Biochem J. 1992 Dec 15;288 ( Pt 3)(Pt 3):1037-44. doi: 10.1042/bj2881037. Biochem J. 1992. PMID: 1471976 Free PMC article.
-
Isolation and characterization of distinct domains of sarcolemma and T-tubules from rat skeletal muscle.Biochem J. 1995 Apr 1;307 ( Pt 1)(Pt 1):273-80. doi: 10.1042/bj3070273. Biochem J. 1995. PMID: 7536412 Free PMC article.
-
Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain.Hum Genet. 1996 Feb;97(2):232-9. doi: 10.1007/BF02265272. Hum Genet. 1996. PMID: 8566960
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources